0
ARTICLE |

Streptomycin and Dihydrostreptomycin

JAMA. 1959;169(11):1268. doi:10.1001/jama.1959.03000280120027.
Text Size: A A A
Published online

ABSTRACT

This book provides a clear and reasonably complete exposition of the history, properties, methods of susceptibility-testing and assay, bacterial resistance and synergism with other antimicrobials, pharmacology, untoward reactions, and uses in various types of clinical infections, including application in combination with other antibiotics, of streptomycin and dihydrostreptomycin. A brief final chapter describes the use of streptomycin in the isolation and culture of viruses. Although the authors have not attempted to review all previously reported studies, the book takes into account most of the important published papers on the streptomycins. It is unfortunate that no reference was made to the study reported by Wier and co-workers (Dis. Chest30:628-632 [Dec.] 1956) which revealed that, from the standpoint of hearing impairment only, therapy with the combination of streptomycin-dihydrostreptomycin ( Streptoduocin ) may be more hazardous than with streptomycin alone. The bibliography provided is extensive and is annotated in the text. A subject index

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs